84 related articles for article (PubMed ID: 21890356)
1. Conformationally constrained farnesoid X receptor (FXR) agonists: alternative replacements of the stilbene.
Akwabi-Ameyaw A; Caravella JA; Chen L; Creech KL; Deaton DN; Madauss KP; Marr HB; Miller AB; Navas F; Parks DJ; Spearing PK; Todd D; Williams SP; Wisely GB
Bioorg Med Chem Lett; 2011 Oct; 21(20):6154-60. PubMed ID: 21890356
[TBL] [Abstract][Full Text] [Related]
2. FXR agonist activity of conformationally constrained analogs of GW 4064.
Akwabi-Ameyaw A; Bass JY; Caldwell RD; Caravella JA; Chen L; Creech KL; Deaton DN; Madauss KP; Marr HB; McFadyen RB; Miller AB; Navas F; Parks DJ; Spearing PK; Todd D; Williams SP; Bruce Wisely G
Bioorg Med Chem Lett; 2009 Aug; 19(16):4733-9. PubMed ID: 19586769
[TBL] [Abstract][Full Text] [Related]
3. Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064.
Bass JY; Caldwell RD; Caravella JA; Chen L; Creech KL; Deaton DN; Madauss KP; Marr HB; McFadyen RB; Miller AB; Parks DJ; Todd D; Williams SP; Wisely GB
Bioorg Med Chem Lett; 2009 Jun; 19(11):2969-73. PubMed ID: 19410460
[TBL] [Abstract][Full Text] [Related]
4. Conformationally constrained farnesoid X receptor (FXR) agonists: heteroaryl replacements of the naphthalene.
Bass JY; Caravella JA; Chen L; Creech KL; Deaton DN; Madauss KP; Marr HB; McFadyen RB; Miller AB; Mills WY; Navas F; Parks DJ; Smalley TL; Spearing PK; Todd D; Williams SP; Wisely GB
Bioorg Med Chem Lett; 2011 Feb; 21(4):1206-13. PubMed ID: 21256005
[TBL] [Abstract][Full Text] [Related]
5. Conformationally constrained farnesoid X receptor (FXR) agonists: Naphthoic acid-based analogs of GW 4064.
Akwabi-Ameyaw A; Bass JY; Caldwell RD; Caravella JA; Chen L; Creech KL; Deaton DN; Jones SA; Kaldor I; Liu Y; Madauss KP; Marr HB; McFadyen RB; Miller AB; Navas F; Parks DJ; Spearing PK; Todd D; Williams SP; Wisely GB
Bioorg Med Chem Lett; 2008 Aug; 18(15):4339-43. PubMed ID: 18621523
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacological validation of a novel series of non-steroidal FXR agonists.
Abel U; Schlüter T; Schulz A; Hambruch E; Steeneck C; Hornberger M; Hoffmann T; Perović-Ottstadt S; Kinzel O; Burnet M; Deuschle U; Kremoser C
Bioorg Med Chem Lett; 2010 Aug; 20(16):4911-7. PubMed ID: 20638278
[TBL] [Abstract][Full Text] [Related]
7. Novel heterocyclic scaffolds of GW4064 as farnesoid X receptor agonists.
Smalley TL; Boggs S; Caravella JA; Chen L; Creech KL; Deaton DN; Kaldor I; Parks DJ
Bioorg Med Chem Lett; 2015 Jan; 25(2):280-4. PubMed ID: 25499883
[TBL] [Abstract][Full Text] [Related]
8. Fragmentation of GW4064 led to a highly potent partial farnesoid X receptor agonist with improved drug-like properties.
Flesch D; Gabler M; Lill A; Gomez RC; Steri R; Schneider G; Stark H; Schubert-Zsilavecz M; Merk D
Bioorg Med Chem; 2015 Jul; 23(13):3490-8. PubMed ID: 25934227
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064.
Martínez-Fernández P; Hierro L; Jara P; Alvarez L
Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1119-29. PubMed ID: 19228886
[TBL] [Abstract][Full Text] [Related]
10. Knocking on FXR's door: the "hammerhead"-structure series of FXR agonists - amphiphilic isoxazoles with potent in vitro and in vivo activities.
Gege C; Kinzel O; Steeneck C; Schulz A; Kremoser C
Curr Top Med Chem; 2014; 14(19):2143-58. PubMed ID: 25388536
[TBL] [Abstract][Full Text] [Related]
11. Medicinal chemistry of farnesoid X receptor ligands: from agonists and antagonists to modulators.
Merk D; Steinhilber D; Schubert-Zsilavecz M
Future Med Chem; 2012 May; 4(8):1015-36. PubMed ID: 22650242
[TBL] [Abstract][Full Text] [Related]
12. Structural basis of tropifexor as a potent and selective agonist of farnesoid X receptor.
Jiang L; Xiao D; Li Y; Dai S; Qu L; Chen X; Guo M; Wei H; Chen Y
Biochem Biophys Res Commun; 2021 Jan; 534():1047-1052. PubMed ID: 33121679
[TBL] [Abstract][Full Text] [Related]
13. Novel substituted isoxazole FXR agonists with cyclopropyl, hydroxycyclobutyl and hydroxyazetidinyl linkers: Understanding and improving key determinants of pharmacological properties.
Kinzel O; Steeneck C; Schlüter T; Schulz A; Gege C; Hahn U; Hambruch E; Hornberger M; Spalwisz A; Frick K; Perović-Ottstadt S; Deuschle U; Burnet M; Kremoser C
Bioorg Med Chem Lett; 2016 Aug; 26(15):3746-53. PubMed ID: 27268696
[TBL] [Abstract][Full Text] [Related]
14. The nuclear receptor FXR is expressed in pancreatic beta-cells and protects human islets from lipotoxicity.
Popescu IR; Helleboid-Chapman A; Lucas A; Vandewalle B; Dumont J; Bouchaert E; Derudas B; Kerr-Conte J; Caron S; Pattou F; Staels B
FEBS Lett; 2010 Jul; 584(13):2845-51. PubMed ID: 20447400
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of Novel Farnesoid X Receptor Agonists and Validation of Their Efficacy in Activating Differentiation of Mouse Bone Marrow-Derived Mesenchymal Stem Cells into Osteoblasts.
Fujimori K; Iguchi Y; Yamashita Y; Gohda K; Teno N
Molecules; 2019 Nov; 24(22):. PubMed ID: 31744088
[TBL] [Abstract][Full Text] [Related]
16. VPAC1 expression is regulated by FXR agonists in the human gallbladder epithelium.
Chignard N; Mergey M; Barbu V; Finzi L; Tiret E; Paul A; Housset C
Hepatology; 2005 Sep; 42(3):549-57. PubMed ID: 16037943
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and evaluation of non-steroidal farnesoid X receptor (FXR) antagonist.
Kainuma M; Makishima M; Hashimoto Y; Miyachi H
Bioorg Med Chem; 2007 Apr; 15(7):2587-600. PubMed ID: 17292610
[TBL] [Abstract][Full Text] [Related]
18. Pyrrole[2,3-d]azepino compounds as agonists of the farnesoid X receptor (FXR).
Mehlmann JF; Crawley ML; Lundquist JT; Unwalla RJ; Harnish DC; Evans MJ; Kim CY; Wrobel JE; Mahaney PE
Bioorg Med Chem Lett; 2009 Sep; 19(18):5289-92. PubMed ID: 19683924
[TBL] [Abstract][Full Text] [Related]
19. Unbinding pathways of GW4064 from human farnesoid X receptor as revealed by molecular dynamics simulations.
Li W; Fu J; Cheng F; Zheng M; Zhang J; Liu G; Tang Y
J Chem Inf Model; 2012 Nov; 52(11):3043-52. PubMed ID: 23101941
[TBL] [Abstract][Full Text] [Related]
20. [Progress in the ligands and their complex structures of farnesoid X receptor].
Li WH; Fu J; Zheng MY; Liu GX; Tang Y
Yao Xue Xue Bao; 2012 Jun; 47(6):704-15. PubMed ID: 22919716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
